BioArctic AB (publ) (BIOA-B.ST) - Stock Prices, Stock Peers & Analysis

Home
BIOA-B.ST

Company Name	BioArctic AB (publ)
Symbol	BIOA-B.ST
Currency	SEK
Price	227.8
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	16,779,748,000
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	191.5 - 392
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Gunilla Osswald Ph.D.
Website	https://www.bioarctic.se

An error occurred while fetching data.

About BioArctic AB (publ)

BioArctic AB (publ), a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, which is in Phase III clinical trials targeting the toxic amyloid-beta oligomers/protofibrils in Alzheimer's disease; and is in preclinical trials for treating Down's syndrome with dementia and